NDC 0024-0674
Sarclisa Escena 140 mg per 1 mL injection, solution
On the label: Sanofi-Aventis U.S. LLC.
Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Sanofi Winthrop Industrie | Vitry sur-Seine, France | Makes the active ingredient and tests it | Problems found, fixed voluntarilyOct 4, 2024 · 6 inspections |
| Sanofi-Aventis Deutschland GmbH | Frankfurt am Main, Germany | Makes it, tests it, packages it and labels it | Problems found, fixed voluntarilyMar 25, 2022 · 10 inspections, 1 with FDA action |
| Eurofins Biopharma Product Testing Ireland Limited | Ireland | Tests it | Problems found, fixed voluntarilyMay 26, 2023 · 5 inspections |
| Genzyme Corporation | Northborough, MA, United States | Tests it, packages it and labels it | No problems foundAug 14, 2025 · 6 inspections |
Product details
- Generic drug
- Isatuximab: every company that makes it
- Form
- injection, solution, subcutaneous
- Strength
- 140 mg per 1 mL
- Approval
- BLA BLA761445
- On the market since
- Jul 9, 2026
- Package NDCs
0024-0674-01- Official label
- DailyMed (National Library of Medicine), updated Jul 10, 2026
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?